Abstract:
Introduction. Raynaud’s Syndrome is caused by vasospasm of the small vessels of the fingers,
toes, nose, chin, ears, and other protruding parts of the body, triggered by cold and/or emotional stress.
It consists of two or three phases (bi- or triphasic) characterized by an initial blanching (ischemia),
followed by cyanosis (anoxia) and rubor (reperfusion). The medical importance of Raynaud’s syndrome
(RS) is to a large extent determined by whether it is a reflection of an underlying autoimmune rheumatic
or connective tissue disease as Systemic Sclerosis, Systemic Lupus Erythematosus and Rheumatoid
Arhtritis.
The aim of this study was to assess the frequency and the particularities of Raynaud’s syndrome
in patients with Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE) and Rheumatoid
Arthritis (RA) in Republic of Moldova.Material and methods.We performed a retrospective study, in which were included 150 patients
who were hospitalized in the Rheumatology department of Republican Clinical Hospital, during the
years 2013-2015: 50 (49 women) of them with SSc, 50 (44 women) with SLE and another 50 (45 women)
with RA. The average age of the patients with SSc was 44,5 ± 18 years, with SLE – 38 ± 13 years and
with AR – 39 ± 8 years.Conclusion. The prevalence of secondary RS depends upon the underlying disease. RS
secondary to autoimmune disease are more common in women than in men. In SSc the evolution of RS
depends on the anti-centromere and anti-Scl70 antibodies.The triphasic feature of RS in SSc was found
in only 11,1% patients. RS appears to develop relatively soon after RA and SLE diagnosis in the majority
of cases.
Description:
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016